Screener
Alto Neuroscience ANRO Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accrued payroll, vacation and employee-related expenses | $2,001 | $4,870 |
| Accrued research | 3,142 | 2,124 |
| Accrued interest, short term | 115 | 118 |
| Other accruals and current liabilities | 1,048 | 599 |
| Lease liability, short term | 1,304 | 1,151 |
| Total accrued expenses and other current liabilities | $7,610 | $8,862 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Alto Neuroscience's accrued expenses?
- Alto Neuroscience (ANRO) reported accrued expenses of $2M in Q1 2026.
- How has Alto Neuroscience's accrued expenses changed year-over-year?
- Alto Neuroscience's accrued expenses decreased by 1.8% year-over-year, from $2.04M to $2M.
- What is the long-term trend for Alto Neuroscience's accrued expenses?
- Over 2 years (2023 to 2025), Alto Neuroscience's accrued expenses has grown at a 3.6% compound annual growth rate (CAGR), from $4.54M to $4.87M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Alto Neuroscience's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude